doi: 10.1007/s12325-019-01101-6 Retrieved from
In a randomized, dounble-blind clinical trial, we have shown that the innovative Sucrosomial B12 formulation rapidly achieve considerably higher and maintained circulatory B12 levels, overcoming the deficiency-borderline threshold (200300 pg/mL) within 24 h with a single 1,000 g dose
Cardiovascular benefits: Clinical trials have demonstrated that tirzepatide can reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes who have established cardiovascular disease
In this study, researchers noticed that when cells in arteries or veins experience damage or stress linked to certain conditions, these cells use the bodys own enzymes to create hydrogen sulfide
Almasio P, Bortolini M, Pagliaro L, Coltorti M